secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK:        0001314052
Form:       8-K
Filed at:   2026-09-02T21:06:24+00:00
Accession:  0001731122-26-001179
Event type: regulatory
Sentiment:  positive
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anavex regains Nasdaq compliance after filing delinquent 10-Qs for Q2 and Q3 FY2026
--------------------------------------------------------------------------------

- Nasdaq confirmed compliance with Listing Rule 5250(c)(1) on September 2, 2026.
- Delinquency notice received May 20, 2026; compliance plan submitted July 20, 2026.
- Filed 10-Qs for periods ended March 31 and June 30, 2026 on August 28, 2026.
- Common stock continues trading on Nasdaq Global Select Market under ticker AVXL.
- Company cites advancing all three core CNS indications as ongoing strategy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1314052/000173112226001179/0001731122-26-001179-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1314052/000173112226001179/e7909_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-26-001179

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer